Cargando…

Impaired Neural Differentiation of Induced Pluripotent Stem Cells Generated from a Mouse Model of Sandhoff Disease

Sandhoff disease (SD) is a glycosphingolipid storage disease that arises from mutations in the Hexb gene and the resultant deficiency in β-hexosaminidase activity. This deficiency results in aberrant lysosomal accumulation of the ganglioside GM2 and related glycolipids, and progressive deterioration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogawa, Yasuhiro, Tanaka, Makoto, Tanabe, Miho, Suzuki, Toshihiro, Togawa, Tadayasu, Fukushige, Tomoko, Kanekura, Takuro, Sakuraba, Hitoshi, Oishi, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561340/ https://www.ncbi.nlm.nih.gov/pubmed/23383290 http://dx.doi.org/10.1371/journal.pone.0055856

Ejemplares similares

Abnormal differentiation of Sandhoff disease model mouse-derived multipotent stem cells toward a neural lineage
por: Ogawa, Yasuhiro, et al.
Publicado: (2017)

Lyso-GM2 Ganglioside: A Possible Biomarker of Tay-Sachs Disease and Sandhoff Disease
por: Kodama, Takashi, et al.
Publicado: (2011)

FcRγ-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice
por: Ogawa, Yasuhiro, et al.
Publicado: (2017)

Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
por: Tsukimura, Takahiro, et al.
Publicado: (2021)

In Vivo Delivery of Therapeutic Molecules by Transplantation of Genome-Edited Induced Pluripotent Stem Cells
por: Nakajima, Ittetsu, et al.
Publicado: (2023)

Comparative urinary globotriaosylceramide analysis by thin-layer chromatography-immunostaining and liquid chromatography-tandem mass spectrometry in patients with Fabry disease
por: Shiga, Tomoko, et al.
Publicado: (2021)

Monitoring of anti-drug antibodies and disease-specific biomarkers in three patients from a Japanese Fabry family treated with enzyme replacement therapy
por: Kubota, Takao, et al.
Publicado: (2022)

E-cadherin loss in RMG-1 cells inhibits cell migration and its regulation by Rho GTPases
por: Haraguchi, Misako, et al.
Publicado: (2019)

Anti-drug antibody formation in Japanese Fabry patients following enzyme replacement therapy
por: Tsukimura, Takahiro, et al.
Publicado: (2020)

Fabry disease in a Japanese population-molecular and biochemical characteristics
por: Sakuraba, Hitoshi, et al.
Publicado: (2018)

Clinical and biochemical investigation of male patients exhibiting membranous cytoplasmic bodies in biopsied kidney tissues; a pitfall in diagnosis of Fabry disease
por: Sakuraba, Hitoshi, et al.
Publicado: (2015)

Development of a Highly Sensitive Immuno-PCR Assay for the Measurement of α-Galactosidase A Protein Levels in Serum and Plasma
por: Nakano, Sachie, et al.
Publicado: (2013)

Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease
por: Sueoka, Hideaki, et al.
Publicado: (2015)

Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease
por: Sueoka, Hideaki, et al.
Publicado: (2015)

Surface plasmon resonance analysis of complex formation of therapeutic recombinant lysosomal enzymes with domain 9 of human cation-independent mannose 6-phosphate receptor
por: Kanzaki, Minori, et al.
Publicado: (2020)

Genetically Modified Cell Transplantation Through Macroencapsulated Spheroids with Scaffolds to Treat Fabry Disease
por: Kami, Daisuke, et al.
Publicado: (2021)

Cerebral organoids derived from Sandhoff disease-induced pluripotent stem cells exhibit impaired neurodifferentiation
por: Allende, Maria L., et al.
Publicado: (2018)

Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease
por: Tsukimura, Takahiro, et al.
Publicado: (2014)

A Case Report of Sandhoff Disease
por: Saouab, R., et al.
Publicado: (2010)

Cell Transplantation Combined with Recombinant Collagen Peptides for the Treatment of Fabry Disease
por: Kami, Daisuke, et al.
Publicado: (2020)

An Infantile Case of Sandhoff Disease Presenting With Swallowing Difficulty
por: Moon, Jae-Gun, et al.
Publicado: (2017)

Gene Expression Profile in the Sandhoff Mouse Brain with Progression of Age
por: Singh, Kshitiz, et al.
Publicado: (2022)

Sandhoff Disease without Hepatosplenomegaly Due to Hexosaminidase B Gene Mutation
por: Gowda, Vykuntaraju K., et al.
Publicado: (2017)

Infantile Sandhoff disease with ventricular septal defect: a case report
por: Sahyouni, Jamal Khaled, et al.
Publicado: (2022)

Clinical and genetic features of a case with juvenile onset sandhoff disease
por: Yin, Jin-Hui, et al.
Publicado: (2023)

Erratum to: Screening of Fabry disease in patients with chronic kidney disease in Japan
por: Nagata, Akiko, et al.
Publicado: (2021)

Screening of Fabry disease in patients with chronic kidney disease in Japan
por: Nagata, Akiko, et al.
Publicado: (2021)

Induced Pluripotent Stem Cells Generated from P0-Cre;Z/EG Transgenic Mice
por: Ogawa, Yasuhiro, et al.
Publicado: (2015)

Effectiveness of immunosuppressive therapy for nephrotic syndrome in a patient with late-onset Fabry disease: a case report and literature review
por: Fujisawa, Hironobu, et al.
Publicado: (2019)

Efficacy of a Bicistronic Vector for Correction of Sandhoff Disease in a Mouse Model
por: Woodley, Evan, et al.
Publicado: (2018)

Peripheral neuropathy in a family with Sandhoff disease and SH3TC2 deficiency
por: Grunseich, Christopher, et al.
Publicado: (2015)

Infantile Type Sandhoff Disease with Striking Brain MRI Findings and a Novel Mutation
por: Beker-Acay, Mehtap, et al.
Publicado: (2016)

Case of late-onset Sandhoff disease due to a novel mutation in the HEXB gene
por: Sung, Angela R., et al.
Publicado: (2018)

Beneficial Effects of Acetyl-DL-Leucine (ADLL) in a Mouse Model of Sandhoff Disease
por: Kaya, Ecem, et al.
Publicado: (2020)

A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases
por: Ou, Li, et al.
Publicado: (2020)

Effect of Yuzu (Citrus junos) Seed Limonoids and Spermine on Intestinal Microbiota and Hypothalamic Tissue in the Sandhoff Disease Mouse Model
por: Minamisawa, Mayumi, et al.
Publicado: (2021)

Novel Mutations in Sandhoff Disease: A Molecular Analysis among Iranian Cohort of Infantile Patients
por: Aryan, H, et al.
Publicado: (2012)

Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases
por: Lyn, Nicole, et al.
Publicado: (2020)

Infantile onset Sandhoff disease: clinical manifestation and a novel common mutation in Thai patients
por: Tim-Aroon, Thipwimol, et al.
Publicado: (2021)

Rapid Immunochromatographic Detection of Serum Anti-α-Galactosidase A Antibodies in Fabry Patients after Enzyme Replacement Therapy
por: Nakano, Sachie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a5tf4o3i6p4tqfks843c9ajp9a